News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BMW is a buy for a 180-day horizon, citing a strong product cycle, scaling EVs, and cost discipline.
  • MPLX offers a 7%+ distribution yield with mid-single-digit EBITDA growth potential and income cushioning downside.
  • Sandisk is a buy on AI infrastructure-driven revenue, high margins, and strong free cash flow after a pullback.
  • Antero Resources looks vulnerable; a mid-term short targets $32 from $39 if weather-driven gas strength fades.
  • X-Energy is a long-term buy for high-temperature reactor and TRISO fuel optionality, tied to milestones.
  • NVIDIA is a guidance-driven buy after upside guidance and AI revenue acceleration, with a $391 target.
  • Hold Tyra Biosciences ahead of the Sept 9 IR-NMIBC readout due to financing risk and a binary clinical event.

Latest Articles

Ryman Hospitality Properties, Inc. Closes Acquisition of Grande Lakes Orlando Resort and Updates 2026 Outlook

Ryman Hospitality Properties, Inc. Closes Acquisition of Grande Lakes Orlando Resort and Updates 2026 Outlook

Ryman Hospitality Properties, Inc. has finalized its acquisition of Grande Lakes Orlando Resort for approximately $1.38 billion, aiming to expand its presence in the upscale convention and group-oriented resort market. The acquisition is expected to bolster Ryman's market position in the largest U.S. meetings market and contribute positively to its…

BofA Lowers PG&E Rating to Neutral After California Wildfire Law Falls Short

BofA Lowers PG&E Rating to Neutral After California Wildfire Law Falls Short

Bank of America downgraded PG&E Corp. to Neutral from Buy and reduced its price target to $13 from $24, citing that California's recent wildfire legislation, Senate Bill 492, improves survivor protections but does not deliver the enduring liability or financing framework the utility needs to underpin its large investment program. The bank now model…

Tantech Holdings Ltd. Announces Reverse Split Record Date

Tantech Holdings Ltd. Announces Reverse Split Record Date

Tantech Holdings Ltd. declared a reverse stock split of its Class A common shares at a ratio of 1-for-50. The reverse split will be effective on September 3, 2026, adjusting share count from approximately 33.4 million to around 667,647 shares. The common shares will continue to trade on Nasdaq under the same ticker symbol TANH but with a new CUSIP …

Phillips Edison & Company Raises Monthly Dividend

Phillips Edison & Company Raises Monthly Dividend

Phillips Edison & Company, a leading owner and operator of grocery-anchored neighborhood shopping centers in the United States, has declared a 6.2% increase in its monthly dividend to $0.115 per share, effective October through December 2026. This marks the sixth consecutive annual dividend increase and demonstrates the company's strong cash flow a…

Bitdeer Announces Acquisition of 200 Acres Near Rockdale Facility in Milam County, Texas to Support AI/HPC Infrastructure Development

Bitdeer Announces Acquisition of 200 Acres Near Rockdale Facility in Milam County, Texas to Support AI/HPC Infrastructure Development

Bitdeer Technologies Group announced the acquisition of 200 acres of land near its existing Rockdale facility in Milam County, Texas. This acquisition, valued at $100 million, enhances Bitdeer's long-term control over site development and supports its strategy to expand AI/HPC and Bitcoin mining infrastructure. The Rockdale site features significan…

Astera Labs to Participate in the Citi 2026 Global TMT Conference

Astera Labs to Participate in the Citi 2026 Global TMT Conference

Astera Labs, a Nasdaq-listed company specializing in semiconductor connectivity solutions for AI infrastructure, announced its participation at the Citi 2026 Global TMT Conference. The company will present its Intelligent Connectivity Platform and custom solutions designed to optimize rack-scale AI deployment, with the session webcast available on …

Root Insurance and Carvana Extend Embedded Insurance Agreement

Root Insurance and Carvana Extend Embedded Insurance Agreement

Root Insurance has extended its exclusive embedded insurance partnership with Carvana until at least August 2028. Since launching their integrated 'Carvana Insurance Built with Root' product in 2022, the collaboration has sold over 200,000 policies, offering a seamless 3-click insurance purchase experience that simplifies buying car insurance durin…

EuroHoldings Ltd. Announces Charter Contract Extensions for Two of its Feeder Containerships, M/V Joanna and M/V Aegean Express

EuroHoldings Ltd. Announces Charter Contract Extensions for Two of its Feeder Containerships, M/V Joanna and M/V Aegean Express

EuroHoldings Ltd. announced the extension of time charter contracts for its two feeder containerships, M/V Joanna and M/V Aegean Express, at significantly higher daily rates than previous contracts. These contracts will generate approximately $24 million in EBITDA over the minimum contracted period and enhance the company's charter coverage through…

BBOT to Participate in Upcoming Investor Healthcare Conferences

BBOT to Participate in Upcoming Investor Healthcare Conferences

BridgeBio Oncology Therapeutics, a clinical-stage biopharmaceutical company focusing on RAS-pathway malignancies, announced participation by its leadership in three major investor healthcare conferences in September 2026. They will present their latest developments in next-generation therapeutics targeting RAS and PI3Kα malignancies, with live webc…

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Ultragenyx Pharmaceutical announced the publication of the 96-week data from its Phase 3 trial of GENGLYCOS (DTX401), an AAV gene therapy for glycogen storage disease type Ia (GSDIa). The study showed a significant 61% mean reduction in daily cornstarch intake while maintaining glycemic control, including elimination of nighttime dosing in a substa…

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences, a Nasdaq-listed cell analysis solutions company, announced its participation in three major upcoming healthcare investor conferences in September 2026, including Wells Fargo, Morgan Stanley, and Deutsche Bank events. Company leadership will engage in meetings and a fireside chat to discuss business prospects and innovations. The …

CAMP4 to Participate in Upcoming Investor Conferences

CAMP4 to Participate in Upcoming Investor Conferences

CAMP4 Therapeutics Corporation, a clinical-stage biopharmaceutical company focused on RNA-targeting therapeutics for genetic diseases, announced its participation in the Wells Fargo 21st Annual Healthcare Conference and the Cantor Global Healthcare Conference in September 2026. The company will present through meetings and a fireside chat, with web…

Greenlight Capital Re, Ltd. Announces New Director Appointments

Greenlight Capital Re, Ltd. Announces New Director Appointments

Greenlight Capital Re announced the appointments of John Welch and Ariel Warszawski as new independent directors to its board. These appointments are expected to bolster the company's leadership with broad expertise in reinsurance, underwriting, investment, and business strategy, supporting Greenlight Re's continued growth and innovation in the pro…

Sana Biotechnology to Present at September 2026 Investor Conferences

Sana Biotechnology to Present at September 2026 Investor Conferences

Sana Biotechnology, a NASDAQ-listed biotechnology company focused on engineered cell therapies, will present business updates and an overview at four major healthcare investor conferences in September 2026. Presentations will be webcast and include updates on the company's strategy, operations, and prospects. The company emphasizes its commitment t…